Author

C. Reicherts

h-index 11 View on Semantic Scholar

We have 2 of 53 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib.

Not available.

Laura Polmann, C. Schliemann, L. M. Sgonina et al. · Haematologica · 0 citations

Open access Aug 2026

Gp120-Activated Allogeneic Regulatory T cells for Prevention of Graft-versus-Host-Disease - a First-in-Human Trial.

These first clinical data support the feasibility and favorable safety profile of ATreg, a third-party, gp120-activated Treg product requiring no ex vivo expansion, and warrant further evaluation in larger prospective clinical trials.

A. Tuettenberg, L. Ruhnke, J. Schlöder et al. · Transplantation and Cellular... · 0 citations